Document is current
Any future updates will be listed below
-
Authors
Harrison, Claire N
Schaap, Nicolaas
Mesa, Ruben A
- License Information
-
More Information
Article History
Received: 10 March 2020
Accepted: 12 March 2020
First Online: 20 March 2020
Compliance with ethical standards
:
: CNH received research fees from Novartis and speaker payments from Novartis, Celgene, Roche, and Jannsen and participated in advisory boards for Sierra Oncology, Promedior, Celgene, and Novartis. RAM received consultant fees from Novartis, Sierra, and La Jolla Pharmaceutical Company and received research support from Celgene, Incyte, Abbvie, Samus Therapeutics, Genotech, Promedior, and CTI Biopharma. NC declares no conflicts of interest.
